Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-04-16 @ 11:07 PM
Study NCT ID:
NCT05845268
Status:
UNKNOWN
Last Update Posted:
2023-05-06
First Post:
2023-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
Sponsor:
Beijing Friendship Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BFH-TNT-LARC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None